ES2197801A1 - Procedimiento de obtension de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-piperidin-1-l)-etil)-2-metil-6,7,8,9-tetrahidro-4h, pirido-(1,2-a)piramidin-4-ona - Google Patents

Procedimiento de obtension de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-piperidin-1-l)-etil)-2-metil-6,7,8,9-tetrahidro-4h, pirido-(1,2-a)piramidin-4-ona

Info

Publication number
ES2197801A1
ES2197801A1 ES200200531A ES200200531A ES2197801A1 ES 2197801 A1 ES2197801 A1 ES 2197801A1 ES 200200531 A ES200200531 A ES 200200531A ES 200200531 A ES200200531 A ES 200200531A ES 2197801 A1 ES2197801 A1 ES 2197801A1
Authority
ES
Spain
Prior art keywords
pyrido
pyrimidin
tetrahydro
methyl
isoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200200531A
Other languages
English (en)
Other versions
ES2197801B1 (es
Inventor
Ambros Rafael Foguet
Massana Jorge Ramentol
Cano Diego Fernandez
Montserrat Miguel P Armengol
Camprubi Francesc X Camps
Rosell Juan Sallares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200200531A priority Critical patent/ES2197801B1/es
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to BR0308139-7A priority patent/BR0308139A/pt
Priority to NZ534463A priority patent/NZ534463A/en
Priority to US10/503,478 priority patent/US7205405B2/en
Priority to AU2003219010A priority patent/AU2003219010A1/en
Priority to RU2004129763/04A priority patent/RU2272037C9/ru
Priority to JP2003572990A priority patent/JP2005525366A/ja
Priority to PCT/EP2003/002157 priority patent/WO2003074522A1/en
Priority to CA002474811A priority patent/CA2474811A1/en
Priority to CNB038044870A priority patent/CN1315826C/zh
Priority to MXPA04008289A priority patent/MXPA04008289A/es
Priority to UA20040907250A priority patent/UA80114C2/uk
Priority to EP03714770A priority patent/EP1480978A1/en
Priority to PL03370502A priority patent/PL370502A1/xx
Priority to KR1020047013537A priority patent/KR100680003B1/ko
Priority to IL16375003A priority patent/IL163750A0/xx
Publication of ES2197801A1 publication Critical patent/ES2197801A1/es
Priority to ZA200405939A priority patent/ZA200405939B/en
Priority to MA27800A priority patent/MA26353A1/fr
Priority to TNP2004000139A priority patent/TNSN04139A1/en
Priority to NO20043447A priority patent/NO20043447L/no
Priority to CO04085289A priority patent/CO5611140A2/es
Priority to CR7462A priority patent/CR7462A/es
Publication of ES2197801B1 publication Critical patent/ES2197801B1/es
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Procedimiento de obtención de la 3-{2-[4-(6-fluoro- benzo[d]isoxazol-3-il)-piperidin-1-il]etil}-2-metil-6,7,8,9- tetrahidro-4H-pirido-[1,2-a]pirimidin-4-ona. Consiste en la condensación del (2-metil-4-oxo-6,7,8,9-tetrahidro-4H-pirido[1,2- a]pirimidin-3-il)-acetaldehído con el 6-fluoro-3-(4-piperidinil)- 1,2-benzisoxazol para dar lugar a la enamina intermedia 3-{2-[4- (6-fluoro-benzo[d]isoxazol-3-il)-piperidin-1-il]-vinil}-2-metil- 6,7,8,9-tetrahidro-pirido[1,2-a]pirimidin-4-ona seguido de reducción de la misma.
ES200200531A 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona. Expired - Fee Related ES2197801B1 (es)

Priority Applications (22)

Application Number Priority Date Filing Date Title
ES200200531A ES2197801B1 (es) 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
KR1020047013537A KR100680003B1 (ko) 2002-03-05 2003-03-03 3-(2-(4-(6-플로로벤조(ｄ)아이소옥사졸-3-일)-피페리딘-1-일)-에틸)-2-메틸-6,7,8,9-테트라하이드로-4ｈ-피리도-(1,2-ａ)피리미딘-4-온의 제조방법
NZ534463A NZ534463A (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-a) pyrimidin-4-one
IL16375003A IL163750A0 (en) 2002-03-05 2003-03-03 Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,
RU2004129763/04A RU2272037C9 (ru) 2002-03-05 2003-03-03 Способ получения 3-{2-[4-(6-фторбензо[d]изоксазол-3-ил)пиперидин-1-ил]этил}-2-метил-6,7,8,9-тетрагидро-4н-пиридо[1,2-а]пиримидин-4-она, промежуточные производные для его получения и способ получения промежуточного производного
JP2003572990A JP2005525366A (ja) 2002-03-05 2003-03-03 ３−｛２−［４−（６−フルオロベンゾ［ｄ］イソオキサゾール−３−イル）−ピペリジン−１−イル］−エチル｝−２−メチル−６，７，８，９−テトラヒドロ−４Ｈ−ピリド−［１，２−ａ］ピリミジン−４−オンの調製方法
PCT/EP2003/002157 WO2003074522A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
CA002474811A CA2474811A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
CNB038044870A CN1315826C (zh) 2002-03-05 2003-03-03 用于制备3－(2－(4－(6－氟苯并(d)异噁唑－3－基)－哌啶－1－基)－乙基)－2－甲基－6,7,8,9－四氢－4h－吡啶并－(1,2－a)嘧啶－4－酮的方法
MXPA04008289A MXPA04008289A (es) 2002-03-05 2003-03-03 Procedimiento de obtencion de la 3- {2-[4 -(6-fluorobenzo [d]isoxazol- 3-il) piperidin- 1-il] -etil}-2 -metil-6, 7, 8, 9-tetrahidro- 4h-pirido -[1, 2-a] pirimidin -4-ona.
UA20040907250A UA80114C2 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one and derivatives
EP03714770A EP1480978A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
BR0308139-7A BR0308139A (pt) 2002-03-05 2003-03-03 Processo para preparação de 3-(2-(4-(6-fluorbenzo(d)isoxazol-3-il)-piperidin-1-il)-etil )-2-metil-6,7,8,9-tetraidro-4h-pirido-(1,2-a)-pirimidin-4-o na
US10/503,478 US7205405B2 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one
AU2003219010A AU2003219010A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
PL03370502A PL370502A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
ZA200405939A ZA200405939B (en) 2002-03-05 2004-07-26 Process for preparing 3-(2-(4-(6-fluorobenzoÄdÜisoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-a)pyrimidin-4-one
MA27800A MA26353A1 (fr) 2002-03-05 2004-07-27 Procede pour la preparation de 3-{2-[4-(6-fluorobenzo[d] isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-[1,2-a]pyrimidin-4-one
TNP2004000139A TNSN04139A1 (en) 2002-03-05 2004-07-29 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin -4-one
NO20043447A NO20043447L (no) 2002-03-05 2004-08-18 Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on
CO04085289A CO5611140A2 (es) 2002-03-05 2004-08-31 Procedimiento de obtencion de la 3-{2-[4-(6-fluorobenzo[d] isoxazol-3-il)-piperidin-1-il]-etil}-2-metil-6,7,8,9-tetrahidro-4h-pirido-[1,2-a]pirimidin-4-ona
CR7462A CR7462A (es) 2002-03-05 2004-09-03 Procedimiento de obtencion de la 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-il)-piperidin-1-il]-etil}-2-metil-6,7,8,9-tetrahidro-4h-pirido-[1,2-a]pirimidin-4-ona

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200200531A ES2197801B1 (es) 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.

Publications (2)

Publication Number Publication Date
ES2197801A1 true ES2197801A1 (es) 2004-01-01
ES2197801B1 ES2197801B1 (es) 2005-03-16

Family

ID=27772022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200200531A Expired - Fee Related ES2197801B1 (es) 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.

Country Status (22)

Country Link
US (1) US7205405B2 (es)
EP (1) EP1480978A1 (es)
JP (1) JP2005525366A (es)
KR (1) KR100680003B1 (es)
CN (1) CN1315826C (es)
AU (1) AU2003219010A1 (es)
BR (1) BR0308139A (es)
CA (1) CA2474811A1 (es)
CO (1) CO5611140A2 (es)
CR (1) CR7462A (es)
ES (1) ES2197801B1 (es)
IL (1) IL163750A0 (es)
MA (1) MA26353A1 (es)
MX (1) MXPA04008289A (es)
NO (1) NO20043447L (es)
NZ (1) NZ534463A (es)
PL (1) PL370502A1 (es)
RU (1) RU2272037C9 (es)
TN (1) TNSN04139A1 (es)
UA (1) UA80114C2 (es)
WO (1) WO2003074522A1 (es)
ZA (1) ZA200405939B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453521B1 (en) * 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
KR20040025224A (ko) * 2002-09-18 2004-03-24 주식회사 대웅 2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-3-일)아세트알데히드 및 그 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO2001085731A1 (en) * 2000-05-05 2001-11-15 Rpg Life Sciences Limited A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO2001085731A1 (en) * 2000-05-05 2001-11-15 Rpg Life Sciences Limited A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one

Also Published As

Publication number Publication date
CA2474811A1 (en) 2003-09-12
ZA200405939B (en) 2006-06-28
UA80114C2 (en) 2007-08-27
PL370502A1 (en) 2005-05-30
CN1639163A (zh) 2005-07-13
TNSN04139A1 (en) 2007-03-12
WO2003074522A1 (en) 2003-09-12
CN1315826C (zh) 2007-05-16
IL163750A0 (en) 2005-12-18
RU2272037C1 (ru) 2006-03-20
KR100680003B1 (ko) 2007-02-08
NZ534463A (en) 2006-02-24
CR7462A (es) 2005-02-10
JP2005525366A (ja) 2005-08-25
MXPA04008289A (es) 2004-11-26
KR20040091679A (ko) 2004-10-28
CO5611140A2 (es) 2006-02-28
AU2003219010A1 (en) 2003-09-16
MA26353A1 (fr) 2004-10-01
US7205405B2 (en) 2007-04-17
NO20043447L (no) 2004-08-18
EP1480978A1 (en) 2004-12-01
BR0308139A (pt) 2005-01-04
ES2197801B1 (es) 2005-03-16
US20050143395A1 (en) 2005-06-30
RU2272037C9 (ru) 2006-06-20

Similar Documents

Publication Publication Date Title
JP6517976B2 (ja) 炎症性障害の治療のための化合物及びその医薬組成物
NZ598220A (en) Heterocyclic compounds and uses thereof
HK1117521A1 (en) Process for preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3- yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h- pyrido[1,2-a]pyrimidin-4-one palmitate ester
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
JP2012510998A5 (es)
TW200305420A (en) Compounds useful in therapy
CN105732639A (zh) 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类
PE20081341A1 (es) Inhibidores de la actividad de la akt
NZ607527A (en) Fused heteroaryls and their uses
WO2008024415A8 (en) Process for the synthesis of cmhtp and intermediates thereof
NZ591001A (en) Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
WO2008070000A3 (en) Treatment of anxiety with eszopiclone
AU2000255635A1 (en) A process for the preparation of anti-pschotic 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl -6,7,8,9-tetrahydro-2-methyl-4h-pyridol(1,2,-a)pyrimidin-4- one
WO2009116071A3 (en) An improved process for preparation of paliperidone
NO172645B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
WO2006069193A3 (en) Imidazo[4,5-c]pyridine compound and method of antiviral treatment
ES2197801A1 (es) Procedimiento de obtension de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-piperidin-1-l)-etil)-2-metil-6,7,8,9-tetrahidro-4h, pirido-(1,2-a)piramidin-4-ona
NZ600593A (en) Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors
RU2340612C2 (ru) 2-имидазобензотиазолы как лиганды аденозинового рецептора
WO2011030224A3 (en) Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
MX2021002794A (es) Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma.
CZ32995A3 (en) PROCESS FOR PREPARING 3-(2-/4-(6-FLUOROBENZO/ISOXAZOL-3-YL)PIPERIDIN-1-YL/ETHYL)-2-METHYL-6,7,8, 9-TETRAHYDRO-4H-PYRIDO/1,2-a/PYRIMIDIN-4-ONE
SG151251A1 (en) Imidazopyridine compound
WO2006005974A8 (en) A process for the preparation of risperidone
MX2007003426A (es) Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040101

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2197801B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180808